Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C

Cancer Res. 2004 Apr 15;64(8):2705-11. doi: 10.1158/0008-5472.can-03-2475.

Abstract

We and others have previously reported in an in vivo rat colon cancer cell model that cell death precedes and is necessary for the development of a specific antitumoral immune response. To sensitize colon cancer cells to death, we depleted cytochrome c by stable transfection with an antisense construct. Cytochrome c depletion sensitizes human and rat colon cancer cells to a nonapoptotic, nonautophagic death induced by various stimuli. This increased sensitization to a necrosis-like cell death may be related to a decrease in cellular ATP levels and an increase in reactive oxygen species production caused by cytochrome c depletion. In vivo, depletion of cytochrome c decreases the tumorigenicity of colon cancer cells in syngeneic rats without influencing their growth in immune-deficient animals. Furthermore, decreased expression of cytochrome c in tumor cells facilitates in vivo "necrotic" cell death and the induction of a specific immune response. These results delineate a novel strategy to sensitize colon cancer cells to chemotherapy and to increase their immunogenicity in immuno-competent hosts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Cisplatin / pharmacology
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / immunology*
  • Colonic Neoplasms / metabolism
  • Cytochromes c / biosynthesis
  • Cytochromes c / deficiency*
  • Cytochromes c / genetics
  • Cytochromes c / immunology*
  • DNA, Antisense / genetics
  • Down-Regulation
  • Doxorubicin / pharmacology
  • Etoposide / pharmacology
  • HCT116 Cells
  • HT29 Cells
  • Humans
  • Macrophages / immunology
  • Mice
  • Rats
  • Staurosporine / pharmacology
  • Transfection

Substances

  • DNA, Antisense
  • Etoposide
  • Doxorubicin
  • Cytochromes c
  • Staurosporine
  • Cisplatin